Rodeo Therapeutics Corp — Form D/A
Rodeo Therapeutics Corp of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2020-04-02. The offering totals $8.9M, of which $8.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-04-02
- Form: D/A
- Accession: 0001712341-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $8.9M
- Amount sold: $8.9M
- Investors: 9
- Date of first sale: 2018-11-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-327473
Issuer
- Name: Rodeo Therapeutics Corp
- CIK: 0001712341
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 2815 Eastlake Avenue East, Suite 300, SEATTLE, WA, 98102
- Phone: (206) 957-7300
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Margarita Chavez | Director | San Francisco, CA |
| Steve Gillis | Director | New York, NY |
| Katie Hewitt | Director | Ottawa, A6 |
| THONG LE | Director | Seattle, WA |
| Sanford Markowitz | Director | Seattle, WA |
| Asish Xavier | Director | South San Francisco, CA |
| Tadataka Yamada | Director | Philadelphia, PA |
| Ian Howes | Executive Officer | Seattle, WA |
| THONG LE | Executive Officer | Seattle, WA |
| Kendall Mohler | Executive Officer | Seattle, WA |
| Suzanne Rettenmier | Executive Officer | Seattle, WA |
| THONG LE | Promoter | Seattle, WA |
| James Sullivan | Director | San Jose, CA |
| LINDSAY RAYLE | Executive Officer | New York, NY |
| LINDSAY RAYLE | Promoter | New York, NY |
| Joel Marcus | Director | South San Francisco, CA |
| David Schubert | Executive Officer | New York, NY |
| David Schubert | Promoter | New York, NY |
Other filings by this issuer (3)
More